These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25846802)

  • 1. A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.
    Jacobs I; Strijkers GJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC
    Magn Reson Med; 2016 Mar; 75(3):1142-53. PubMed ID: 25846802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
    Hectors SJ; Jacobs I; Lok J; Peters J; Bussink J; Hoeben FJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC; Strijkers GJ
    Cancer Res; 2018 Mar; 78(6):1561-1570. PubMed ID: 29317433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of T
    Zhang J; Winters K; Reynaud O; Kim SG
    NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28544159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI.
    Zhang J; Winters K; Kiser K; Baboli M; Kim SG
    PLoS One; 2020; 15(6):e0234520. PubMed ID: 32520950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle.
    Hindel S; Söhner A; Maaß M; Sauerwein W; Möllmann D; Baba HA; Kramer M; Lüdemann L
    PLoS One; 2017; 12(1):e0170841. PubMed ID: 28141810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size.
    Jaspers K; Leiner T; Dijkstra P; Oostendorp M; van Golde JM; Post MJ; Backes WH
    Med Phys; 2010 Nov; 37(11):5746-55. PubMed ID: 21158286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF.
    Duan C; Kallehauge JF; Pérez-Torres CJ; Bretthorst GL; Beeman SC; Tanderup K; Ackerman JJH; Garbow JR
    Mol Imaging Biol; 2018 Feb; 20(1):150-159. PubMed ID: 28536804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI.
    Singh A; Rathore RK; Haris M; Verma SK; Husain N; Gupta RK
    J Magn Reson Imaging; 2009 Jan; 29(1):166-76. PubMed ID: 19097111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability.
    Heye AK; Thrippleton MJ; Armitage PA; Valdés Hernández MDC; Makin SD; Glatz A; Sakka E; Wardlaw JM
    Neuroimage; 2016 Jan; 125():446-455. PubMed ID: 26477653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis.
    Bisdas S; Konstantinou GN; Lee PS; Thng CH; Wagenblast J; Baghi M; Koh TS
    Phys Med Biol; 2007 Oct; 52(20):6181-96. PubMed ID: 17921579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster analysis of DCE-MRI data identifies regional tracer-kinetic changes after tumor treatment with high intensity focused ultrasound.
    Jacobs I; Hectors SJ; Schabel MC; Grüll H; Strijkers GJ; Nicolay K
    NMR Biomed; 2015 Nov; 28(11):1443-54. PubMed ID: 26390040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
    Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
    NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents.
    Orth RC; Bankson J; Price R; Jackson EF
    Magn Reson Med; 2007 Oct; 58(4):705-16. PubMed ID: 17899608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
    Lee SH; Rimner A; Deasy JO; Hunt MA; Tyagi N
    J Appl Clin Med Phys; 2019 Nov; 20(11):169-188. PubMed ID: 31602789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of contrast agent bolus arrival delays for improved reproducibility of liver DCE MRI.
    Chouhan MD; Bainbridge A; Atkinson D; Punwani S; Mookerjee RP; Lythgoe MF; Taylor SA
    Phys Med Biol; 2016 Oct; 61(19):6905-6918. PubMed ID: 27618594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
    de Lussanet QG; Langereis S; Beets-Tan RG; van Genderen MH; Griffioen AW; van Engelshoven JM; Backes WH
    Radiology; 2005 Apr; 235(1):65-72. PubMed ID: 15731376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.